InflaRx N.V. (IFRX)
NASDAQ: IFRX · IEX Real-Time Price · USD
1.730
0.00 (0.00%)
At close: Jul 2, 2024, 4:00 PM
1.770
+0.040 (2.31%)
After-hours: Jul 2, 2024, 7:50 PM EDT
InflaRx Market Cap
InflaRx has a market cap or net worth of $101.87 million as of July 2, 2024. Its market cap has decreased by -50.21% in one year.
Market Cap
101.87M
Enterprise Value
12.85M
1-Year Change
-50.21%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $350.90M to $101.87M, a decrease of -70.97%. That is a compound annual growth rate of -16.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 100.70M | 4.90% |
| Dec 29, 2023 | 96.00M | -29.93% |
| Dec 30, 2022 | 137.00M | -34.85% |
| Dec 31, 2021 | 210.30M | 60.17% |
| Dec 31, 2020 | 131.30M | 27.72% |
| Dec 31, 2019 | 102.80M | -88.13% |
| Dec 31, 2018 | 866.00M | 76.55% |
| Dec 29, 2017 | 490.50M | 39.78% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oramed Pharmaceuticals | 104.62M |
| KORU Medical Systems | 103.88M |
| Annovis Bio | 103.67M |
| Immunic | 103.59M |
| CytomX Therapeutics | 102.85M |
| Zentek | 101.44M |
| FONAR | 100.62M |
| Karyopharm Therapeutics | 99.69M |